vs
Ponce Financial Group, Inc.（PDLB）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Ponce Financial Group, Inc.的1.1倍（$35.5M vs $31.4M），Ponce Financial Group, Inc.净利率更高（36.3% vs -304.2%，领先340.5%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 37.6%），Ponce Financial Group, Inc.自由现金流更多（$54.6M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 23.7%）
庞塞金融集团是总部位于美国的金融控股公司，核心子公司为庞塞银行，主要服务纽约大都会区的多元文化、移民及中低收入社区，提供存款账户、按揭贷款、小微企业融资、个人信贷等零售及商业银行服务。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
PDLB vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $31.4M | $35.5M |
| 净利润 | $10.1M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 43.6% | -304.8% |
| 净利率 | 36.3% | -304.2% |
| 营收同比 | 37.6% | 681.7% |
| 净利润同比 | 245.6% | 39.6% |
| 每股收益（稀释后） | $0.43 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $31.4M | $35.5M | ||
| Q3 25 | $26.7M | $5.2M | ||
| Q2 25 | $26.5M | $19.2M | ||
| Q1 25 | $24.6M | $14.7M | ||
| Q4 24 | $22.8M | $4.5M | ||
| Q3 24 | $20.2M | $26.1M | ||
| Q2 24 | $20.2M | $14.4M | ||
| Q1 24 | $20.5M | $13.8M |
| Q4 25 | $10.1M | $-108.1M | ||
| Q3 25 | $6.5M | $-162.3M | ||
| Q2 25 | $6.1M | $-171.9M | ||
| Q1 25 | $6.0M | $-202.5M | ||
| Q4 24 | $2.9M | $-178.9M | ||
| Q3 24 | $2.4M | $-95.8M | ||
| Q2 24 | $3.2M | $-97.5M | ||
| Q1 24 | $2.4M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | 43.6% | -304.8% | ||
| Q3 25 | 32.8% | -3327.6% | ||
| Q2 25 | 30.2% | -916.8% | ||
| Q1 25 | 32.5% | -1297.9% | ||
| Q4 24 | 19.6% | -4042.4% | ||
| Q3 24 | 15.2% | -377.1% | ||
| Q2 24 | 21.8% | -697.4% | ||
| Q1 24 | 18.3% | -698.4% |
| Q4 25 | 36.3% | -304.2% | ||
| Q3 25 | 24.3% | -3135.3% | ||
| Q2 25 | 23.0% | -894.2% | ||
| Q1 25 | 24.2% | -1373.3% | ||
| Q4 24 | 14.1% | -3935.5% | ||
| Q3 24 | 12.1% | -367.5% | ||
| Q2 24 | 15.8% | -676.6% | ||
| Q1 24 | 11.8% | -662.4% |
| Q4 25 | $0.43 | $-0.17 | ||
| Q3 25 | $0.27 | $-0.36 | ||
| Q2 25 | $0.25 | $-0.41 | ||
| Q1 25 | $0.25 | $-0.50 | ||
| Q4 24 | $0.11 | $-0.56 | ||
| Q3 24 | $0.10 | $-0.34 | ||
| Q2 24 | $0.14 | $-0.40 | ||
| Q1 24 | $0.11 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $126.2M | $743.3M |
| 总债务越低越好 | $596.1M | $9.6M |
| 股东权益账面价值 | $541.5M | $1.1B |
| 总资产 | $3.2B | $1.5B |
| 负债/权益比越低杠杆越低 | 1.10× | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $126.2M | $743.3M | ||
| Q3 25 | $146.6M | $659.8M | ||
| Q2 25 | $126.6M | $525.1M | ||
| Q1 25 | $129.9M | $500.5M | ||
| Q4 24 | $139.8M | $594.4M | ||
| Q3 24 | $155.8M | $427.6M | ||
| Q2 24 | $103.2M | $474.3M | ||
| Q1 24 | $134.7M | $296.3M |
| Q4 25 | $596.1M | $9.6M | ||
| Q3 25 | $521.1M | $11.9M | ||
| Q2 25 | $536.1M | $14.2M | ||
| Q1 25 | $521.1M | $16.4M | ||
| Q4 24 | $596.1M | $19.0M | ||
| Q3 24 | $580.4M | $20.5M | ||
| Q2 24 | $680.4M | $22.9M | ||
| Q1 24 | $680.4M | — |
| Q4 25 | $541.5M | $1.1B | ||
| Q3 25 | $529.8M | $1.0B | ||
| Q2 25 | $521.1M | $919.1M | ||
| Q1 25 | $513.9M | $933.9M | ||
| Q4 24 | $505.5M | $1.0B | ||
| Q3 24 | $504.6M | $524.6M | ||
| Q2 24 | $497.7M | $584.4M | ||
| Q1 24 | $493.7M | $401.2M |
| Q4 25 | $3.2B | $1.5B | ||
| Q3 25 | $3.2B | $1.4B | ||
| Q2 25 | $3.2B | $1.3B | ||
| Q1 25 | $3.1B | $1.3B | ||
| Q4 24 | $3.0B | $1.4B | ||
| Q3 24 | $3.0B | $726.5M | ||
| Q2 24 | $2.8B | $775.9M | ||
| Q1 24 | $2.8B | $557.8M |
| Q4 25 | 1.10× | 0.01× | ||
| Q3 25 | 0.98× | 0.01× | ||
| Q2 25 | 1.03× | 0.02× | ||
| Q1 25 | 1.01× | 0.02× | ||
| Q4 24 | 1.18× | 0.02× | ||
| Q3 24 | 1.15× | 0.04× | ||
| Q2 24 | 1.37× | 0.04× | ||
| Q1 24 | 1.38× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $55.6M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $54.6M | $-47.3M |
| 自由现金流率自由现金流/营收 | 173.9% | -133.1% |
| 资本支出强度资本支出/营收 | 3.1% | 3.5% |
| 现金转化率经营现金流/净利润 | 5.48× | — |
| 过去12个月自由现金流最近4个季度 | $74.3M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $55.6M | $-46.1M | ||
| Q3 25 | $1.4M | $-117.4M | ||
| Q2 25 | $6.2M | $-76.4M | ||
| Q1 25 | $13.1M | $-132.0M | ||
| Q4 24 | $7.2M | $-115.4M | ||
| Q3 24 | $-14.6M | $-59.2M | ||
| Q2 24 | $-2.6M | $-82.2M | ||
| Q1 24 | $1.5M | $-102.3M |
| Q4 25 | $54.6M | $-47.3M | ||
| Q3 25 | $786.0K | $-117.6M | ||
| Q2 25 | $5.9M | $-79.6M | ||
| Q1 25 | $12.9M | $-133.8M | ||
| Q4 24 | $4.5M | $-116.7M | ||
| Q3 24 | $-15.0M | $-63.8M | ||
| Q2 24 | $-2.6M | $-83.4M | ||
| Q1 24 | $-315.0K | $-109.0M |
| Q4 25 | 173.9% | -133.1% | ||
| Q3 25 | 2.9% | -2272.5% | ||
| Q2 25 | 22.4% | -413.9% | ||
| Q1 25 | 52.6% | -907.4% | ||
| Q4 24 | 19.7% | -2567.7% | ||
| Q3 24 | -74.1% | -244.6% | ||
| Q2 24 | -13.0% | -578.5% | ||
| Q1 24 | -1.5% | -789.9% |
| Q4 25 | 3.1% | 3.5% | ||
| Q3 25 | 2.3% | 4.7% | ||
| Q2 25 | 1.0% | 16.4% | ||
| Q1 25 | 0.6% | 12.4% | ||
| Q4 24 | 11.9% | 28.6% | ||
| Q3 24 | 2.0% | 17.5% | ||
| Q2 24 | 0.3% | 8.2% | ||
| Q1 24 | 8.7% | 48.2% |
| Q4 25 | 5.48× | — | ||
| Q3 25 | 0.21× | — | ||
| Q2 25 | 1.01× | — | ||
| Q1 25 | 2.20× | — | ||
| Q4 24 | 2.46× | — | ||
| Q3 24 | -5.99× | — | ||
| Q2 24 | -0.80× | — | ||
| Q1 24 | 0.61× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
